These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20571868)

  • 1. Pharmacological interventions for fertility preservation during chemotherapy: a systematic review and meta-analysis.
    Ben-Aharon I; Gafter-Gvili A; Leibovici L; Stemmer SM
    Breast Cancer Res Treat; 2010 Aug; 122(3):803-11. PubMed ID: 20571868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.
    Clowse ME; Behera MA; Anders CK; Copland S; Coffman CJ; Leppert PC; Bastian LA
    J Womens Health (Larchmt); 2009 Mar; 18(3):311-9. PubMed ID: 19281314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.
    Senra JC; Roque M; Talim MCT; Reis FM; Tavares RLC
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):77-86. PubMed ID: 29055060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.
    Munhoz RR; Pereira AA; Sasse AD; Hoff PM; Traina TA; Hudis CA; Marques RJ
    JAMA Oncol; 2016 Jan; 2(1):65-73. PubMed ID: 26426573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and efficacy of gonadotropin-releasing hormone agonists for the prevention of chemotherapy-induced ovarian insufficiency in patients with malignant ovarian germ cell tumours (KGOG 3048R).
    Choi MC; Chung YS; Lee JW; Kwon BS; Park BK; Kim SI; Shim SH; Lee KB; Seong SJ; Lee SJ; Lee SH; Yoo HJ; Song T; Kim MK; Baek MH; Kang S; Kim YM
    Eur J Cancer; 2020 Jul; 133():56-65. PubMed ID: 32442924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study.
    Badawy A; Elnashar A; El-Ashry M; Shahat M
    Fertil Steril; 2009 Mar; 91(3):694-7. PubMed ID: 18675959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors.
    Blumenfeld Z; Zur H; Dann EJ
    Oncologist; 2015 Nov; 20(11):1283-9. PubMed ID: 26463871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protecting Ovaries During Chemotherapy Through Gonad Suppression: A Systematic Review and Meta-analysis.
    Elgindy E; Sibai H; Abdelghani A; Mostafa M
    Obstet Gynecol; 2015 Jul; 126(1):187-95. PubMed ID: 26241272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-Releasing Hormone Analogs for Gonadal Protection During Gonadotoxic Chemotherapy: A Systematic Review and Meta-Analysis.
    Sofiyeva N; Siepmann T; Barlinn K; Seli E; Ata B
    Reprod Sci; 2019 Jul; 26(7):939-953. PubMed ID: 30270741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials.
    Del Mastro L; Ceppi M; Poggio F; Bighin C; Peccatori F; Demeestere I; Levaggi A; Giraudi S; Lambertini M; D'Alonzo A; Canavese G; Pronzato P; Bruzzi P
    Cancer Treat Rev; 2014 Jun; 40(5):675-83. PubMed ID: 24360817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of gonadotropin-releasing hormone agonists for ovarian preservation in patients receiving cyclophosphamide for systemic lupus erythematosus: A meta-analysis.
    Ejaz K; Abid D; Juneau P; Chu J; Hasni S
    Lupus; 2022 Dec; 31(14):1706-1713. PubMed ID: 36148853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Premature ovarian failure after chemotherapy for breast cancer].
    Mathelin C; Brettes JP; Diemunsch P
    Bull Cancer; 2008 Apr; 95(4):403-12. PubMed ID: 18495569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with ovarian function recovery after chemotherapy for breast cancer: a systematic review and meta-analysis.
    Silva C; Caramelo O; Almeida-Santos T; Ribeiro Rama AC
    Hum Reprod; 2016 Dec; 31(12):2737-2749. PubMed ID: 27664208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin-releasing hormone agonists for ovarian protection during breast cancer chemotherapy: a systematic review and meta-analysis.
    Li ZY; Dong YL; Cao XZ; Ren SS; Zhang Z
    Menopause; 2022 Sep; 29(9):1093-1100. PubMed ID: 35917530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonadotropin-releasing hormone for preservation of ovarian function during chemotherapy in lymphoma patients of reproductive age: a summary based on 434 patients.
    Zhang Y; Xiao Z; Wang Y; Luo S; Li X; Li S
    PLoS One; 2013; 8(11):e80444. PubMed ID: 24312222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine prevention of chemotherapy-induced ovarian failure.
    Blumenfeld Z; Evron A
    Curr Opin Obstet Gynecol; 2016 Aug; 28(4):223-9. PubMed ID: 27253235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of ovarian function by GnRH agonists during chemotherapy: a meta-analysis.
    Sun X; Dongol S; Jiang J; Kong B
    Int J Oncol; 2014 Apr; 44(4):1335-40. PubMed ID: 24535045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.
    Bildik G; Akin N; Senbabaoglu F; Sahin GN; Karahuseyinoglu S; Ince U; Taskiran C; Selek U; Yakin K; Guzel Y; Ayhan C; Alper E; Cetiner M; Balaban B; Mandel NM; Esen T; Iwase A; Urman B; Oktem O
    Hum Reprod; 2015 Dec; 30(12):2912-25. PubMed ID: 26466909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of gonadal function in women undergoing chemotherapy: a systematic review and meta-analysis of the potential role for gonadotropin-releasing hormone agonists.
    Hickman LC; Llarena NC; Valentine LN; Liu X; Falcone T
    J Assist Reprod Genet; 2018 Apr; 35(4):571-581. PubMed ID: 29470701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis.
    Bedaiwy MA; Abou-Setta AM; Desai N; Hurd W; Starks D; El-Nashar SA; Al-Inany HG; Falcone T
    Fertil Steril; 2011 Mar; 95(3):906-14.e1-4. PubMed ID: 21145541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.